Abstract
OKT3 is a very effective drug when used for reversal of acute allograft rejection. The excellent long-term graft survival of the patients in this study indicates that it is also an effective adjunctive therapy for promoting long-term graft survival. The problems encountered with early rerejection in high responder patients will promote an alteration of currently used protocols to accommodate these patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 39-41 |
| Number of pages | 3 |
| Journal | Transplantation proceedings |
| Volume | 17 |
| Issue number | 1 I |
| State | Published - 1985 |
ASJC Scopus subject areas
- Surgery
- Transplantation